Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Haleon plc has released its Q1 trading statement for 2025, with a presentation and Q&A session led by CFO Dawn Allen scheduled for April 30...
GSK PLC reports strong Q1 2025 results, driven by Specialty Medicines growth and significant R&D investments, highlighting confidence in future performance...
Nuformix plc (LON:NFX) has received a positive opinion from the EMA for Orphan Drug Designation of NXP002 in treating Idiopathic Pulmonary Fibrosis (IPF)...
Aptamer Group plc has secured a significant global licensing deal with the University of Glasgow, advancing synthetic binders for vaccines in swine health...
One Health Group is transforming healthcare with impressive growth and a commitment to tackling NHS waiting times, solidifying its role as a trusted provider...
Discover hVIVO's groundbreaking RSV-B London strain, a pivotal advancement in respiratory virus research, enhancing vaccine and antiviral development for RSV...
AstraZeneca Plc's Q1 2025 results reveal strong growth and a focus on pipeline delivery, setting the stage for ambitious goals leading to 2030...
Nuformix plc (LON:NFX) has, effective immediately, relocated its registered office to a new London address and appointed Shaun Zulafqar as Company Secretary...
Aptamer Group plc is set to unveil groundbreaking data on its Optimer® delivery vehicle for fibrotic liver disease at the 2025 ASGCT Annual Meeting...
Cizzle Biotechnology announces significant strides in early lung cancer detection through its partner's first Caribbean contract, boosting its biomarker test rollout...
One Health Group's first trading update since its AIM listing reveals over 20% revenue growth, highlighting its strong market position and promising future in healthcare...
EDX Medical Group is set to revolutionise testicular cancer detection with a groundbreaking test boasting over 90% sensitivity...
As concerns over public health rise, understanding influenza's impact on healthcare evolves into a key opportunity for savvy investors in biotech and vaccine development...
Aptamer Group plc has released a new corporate presentation and investor factsheet, showcasing its strategic growth, operational progress, and financial performance in the life science industry...
One Health Group plc's trading update highlights impressive growth in NHS-funded procedures. Discover their revenue surge, new contracts, and plans for expansion...
Introducing the TC100 by EDX Medical: a revolutionary, non-invasive blood test transforming testicular cancer detection with AI precision and unmatched accuracy...
Navigating first-in-human trials requires precision. Learn how integrating real-world patient insights, like cannabis use, enhances drug development for schizophrenia...
DCC plc has agreed to sell its healthcare division to HealthCo Investment for £1.05 billion, streamlining operations and enhancing shareholder value...
The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...
HUTCHMED has successfully completed patient enrollment for a Phase II trial of savolitinib, targeting gastric cancer patients with MET amplification...
Search

Funds

May 30, 2024

Haleon plc has released its Q1 trading statement for 2025, with a presentation and Q&A session led by CFO Dawn Allen scheduled for April 30...
GSK PLC reports strong Q1 2025 results, driven by Specialty Medicines growth and significant R&D investments, highlighting confidence in future performance...
Nuformix plc (LON:NFX) has received a positive opinion from the EMA for Orphan Drug Designation of NXP002 in treating Idiopathic Pulmonary Fibrosis (IPF)...
Aptamer Group plc has secured a significant global licensing deal with the University of Glasgow, advancing synthetic binders for vaccines in swine health...
One Health Group is transforming healthcare with impressive growth and a commitment to tackling NHS waiting times, solidifying its role as a trusted provider...
Discover hVIVO's groundbreaking RSV-B London strain, a pivotal advancement in respiratory virus research, enhancing vaccine and antiviral development for RSV...
AstraZeneca Plc's Q1 2025 results reveal strong growth and a focus on pipeline delivery, setting the stage for ambitious goals leading to 2030...
Nuformix plc (LON:NFX) has, effective immediately, relocated its registered office to a new London address and appointed Shaun Zulafqar as Company Secretary...
Aptamer Group plc is set to unveil groundbreaking data on its Optimer® delivery vehicle for fibrotic liver disease at the 2025 ASGCT Annual Meeting...
Cizzle Biotechnology announces significant strides in early lung cancer detection through its partner's first Caribbean contract, boosting its biomarker test rollout...
One Health Group's first trading update since its AIM listing reveals over 20% revenue growth, highlighting its strong market position and promising future in healthcare...
EDX Medical Group is set to revolutionise testicular cancer detection with a groundbreaking test boasting over 90% sensitivity...
As concerns over public health rise, understanding influenza's impact on healthcare evolves into a key opportunity for savvy investors in biotech and vaccine development...
Aptamer Group plc has released a new corporate presentation and investor factsheet, showcasing its strategic growth, operational progress, and financial performance in the life science industry...
One Health Group plc's trading update highlights impressive growth in NHS-funded procedures. Discover their revenue surge, new contracts, and plans for expansion...
Introducing the TC100 by EDX Medical: a revolutionary, non-invasive blood test transforming testicular cancer detection with AI precision and unmatched accuracy...
Navigating first-in-human trials requires precision. Learn how integrating real-world patient insights, like cannabis use, enhances drug development for schizophrenia...
DCC plc has agreed to sell its healthcare division to HealthCo Investment for £1.05 billion, streamlining operations and enhancing shareholder value...
The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...
HUTCHMED has successfully completed patient enrollment for a Phase II trial of savolitinib, targeting gastric cancer patients with MET amplification...
Search

Funds

Health

FTSE 100

Funds